Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Ritlecitinib is an effective new treatment for Alopecia Areata.

More research is needed on alopecia areata treatments and its psychological effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

New cytokine-targeted therapies show promise for treating alopecia areata.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Apigenin may effectively promote hair growth for androgenetic alopecia when applied topically.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Topical metformin shows promise for skin treatments but needs more testing for safety and effectiveness.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.